Pancreatic Cancer Research

ResearcherUtrecht UniversityNo recent work listed

Richard van Hillegersberg

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7134-261X; OpenAlex author ID A5046588150. Sources: ClinicalTrials.gov.

Their work

Papers
6 (first author 0, last author 1)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2012: 1 paper, 1 trial · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper

Papers 6

  1. Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled… Co-author DOI 10.1186/s13063-021-05248-y↗
  2. Safety of radiofrequency ablation in patients with locally advanced, unresectable pancreatic cancer: A phase II study. Last author DOI 10.1016/j.ejso.2019.06.008↗
  3. Computed tomography findings after radiofrequency ablation in locally advanced pancreatic cancer. Co-author DOI 10.1007/s00261-018-1519-y↗
  4. Systematic review of innovative ablative therapies for the treatment of locally advanced pancreatic cancer. Co-author DOI 10.1002/bjs.9716↗
  5. Radiofrequency ablation for unresectable locally advanced pancreatic cancer: a systematic review. Co-author DOI 10.1111/hpb.12097↗
  6. Pancreatic ductal adenocarcinoma in hereditary diffuse gastric cancer. A case report. Co-author DOI 10.1016/j.humpath.2011.06.008↗

Trials 1

  1. Safety Study of Radiofrequency Ablation of Locally Advanced Pancreatic Cancer Principal investigator NCT01628458↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Izaak Quintus Molenaar · 5 shared papers, 2014–2021 · strength 0.36
  2. Hjalmar C. van Santvoort · 5 shared papers, 2014–2021 · strength 0.36
  3. Marc G. Besselink · 4 shared papers, 2014–2021 · strength 0.27
  4. Marieke S. Walma · 3 shared papers, 2018–2021 · strength 0.25
  5. Maarten Simon van Leeuwen · 3 shared papers, 2018–2021 · strength 0.25
  6. Steffi J. E. Rombouts · 3 shared papers, 2015–2021 · strength 0.22
  7. Ignace H. J. T. de Hingh · 2 shared papers, 2019–2021 · strength 0.17
  8. Samira Fegrachi · 2 shared papers, 2014–2019 · strength 0.14
  9. Krijn P. van Lienden · 2 shared papers, 2015–2021 · strength 0.13
  10. Joost M. Klaase · 1 shared paper, 2019 · strength 0.08
  11. Freek D. Daams · 1 shared paper, 2021 · strength 0.08
  12. Gijs A. Patijn · 1 shared paper, 2021 · strength 0.08
  13. Martijn Ruben Meijerink · 1 shared paper, 2021 · strength 0.08
  14. Johanna W. Wilmink · 1 shared paper, 2021 · strength 0.08
  15. Nadia Haj Mohammad · 1 shared paper, 2021 · strength 0.08
  16. Vincent Erwin de Meijer · 1 shared paper, 2021 · strength 0.08
  17. Sebastiaan Festen · 1 shared paper, 2021 · strength 0.08
  18. Lilly J. H. Brada · 1 shared paper, 2021 · strength 0.08
  19. Poya Ghorbani · 1 shared paper, 2021 · strength 0.08
  20. Judith de Vos‐Geelen · 1 shared paper, 2021 · strength 0.08
  21. Geert Roeyen · 1 shared paper, 2021 · strength 0.08
  22. Martijn W.J. Stommel · 1 shared paper, 2021 · strength 0.08
  23. Elizabeth Pando Rau · 1 shared paper, 2021 · strength 0.08
  24. Jantien A. Vogel · 1 shared paper, 2015 · strength 0.05
  25. Anya N. Milne · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.